Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Forecast to 2021

Publisher Name :
Date: 21-Sep-2016
No. of pages: 166

The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based on products, diseases, techniques, end users, and regions. The assay kits& reagents segment is expected to register the highest growth rate in the ANA testing market, byproduct, during the forecast period. The high growth in this segment is attributed to the growing number of reagent rental agreements and increasing prevalence of autoimmune diseases worldwide.

Based on end users, the ANA testing market is segmented into clinical laboratories, hospitals, POLs, and other end users. The hospitals segment is expected to account for the largest share of the market in 2016. Increasing prevalence of autoimmune diseases, coupled with the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories, will be the major factors driving the growth of this market.

North America is the largest regional segment in the global ANA testing market, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American market is primarily driven by the rising geriatric population and the growing number of people covered under medical insurance in the U.S.

In addition to comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles in this report comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach and levels of output in order to remain successful in the ANA testing market.

The major players in this market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).

Objectives of the Study:


  • To define, describe, and forecast the global antinuclear antibody testing market on the basis of product, technique, disease, and end user

  • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and trends)

  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)

  • To strategically analyze the market structure and profile the key players operating in the global ANA testing market and comprehensively analyze their core competencies

  • To track and analyze competitive developments such as new product launches, agreements, expansions, and acquisitions in the global ANA testing market


Target Audience for this Report:


  • ANA Testing Instrument Manufacturers and Suppliers

  • Clinical Laboratories

  • Hospitals

  • Pharmaceutical and Biotechnology Companies

  • Academic Research Institutes Related to Antinuclear Antibody Testing

Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Forecast to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Antinuclear Antibody Test Market Overview
4.2 Life Cycle Analysis, By Region

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 High Incidence of Autoimmune Diseases
5.3.1.2 Increasing Population and Growth in Healthcare Expenditure
5.3.1.3 Growth in the Number of Individuals Covered Under Medical Insurance
5.3.2 Restraints
5.3.2.1 Stringent Regulations for the Approval of Medical Devices
5.3.2.2 Implementation of Excise Duty on Medical Devices in the U.S.
5.3.2.3 Requirement of Significant Capital to Purchase High-Cost Equipment
5.3.3 Opportunities
5.3.3.1 Laboratory Automation
5.3.3.2 Emerging Markets in Asia Present High-Growth Opportunities
5.3.4 Trend
5.3.4.1 Reagent Rental Agreements

6 Antinuclear Antibody Test Market, By Product
6.1 Introduction
6.2 Reagents & Assay Kits
6.3 Systems
6.4 Software & Services

7 Antinuclear Antibody Test Market, By Technique
7.1 Introduction
7.2 Elisa
7.3 Immunofluorescence Assay
7.4 Multiplex Assay

8 Antinuclear Antibody Test Market, By Disease
8.1 Introduction
8.2 Rheumatoid Arthritis
8.3 Systemic Lupus Erythematosus
8.4 Sjögren’s Syndrome
8.5 Scleroderma
8.6 Other Diseases

9 Antinuclear Antibody Test Market, By End User
9.1 Introduction
9.2 Hospitals
9.2.1 Small Hospitals
9.2.2 Mid-Sized Hospitals
9.2.3 Large Hospitals
9.3 Clinical Laboratories
9.4 Physician Office Laboratories
9.5 Other End Users

10 Geographic Analysis
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of the Asia (RoA)
10.5 Rest of the World

11 Competitive Landscape
11.1 Introduction
11.2 Strategic Overview
11.3 Market Share Analysis
11.4 Competitive Situation and Trends
11.4.1 Acquisitions
11.4.2 Agreements
11.4.3 New Product Launches
11.4.4 Expansions
11.4.5 Other Developments

12 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Thermo Fisher Scientific, Inc.
12.3 Alere Inc.
12.4 Bio-Rad Laboratories, Inc.
12.5 Trinity Biotech PLC
12.6 Erba Diagnostics, Inc.
12.7 Antibodies Inc.
12.8 Euroimmun AG
12.9 Immuno Concepts
12.10 Inova Diagnostics
12.11 Zeus Scientific, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables

Table 1 Prevalence Data for Autoimmune Diseases
Table 2 High Incidence of Autoimmune Diseases to Drive Market Growth
Table 3 Implementation of Excise Duty on Medical Devices in the U.S. to Restrain Market Growth
Table 4 Growing Demand for Lab Automation to Offer Major Growth Opportunities
Table 5 Reagent Rental Agreements are an Important Trend in the Antinuclear Antibody Test Market
Table 6 Antinuclear Antibody Testing Market Size, By Product, 2014–2021 (USD Million)
Table 7 Antinuclear Antibody Test Market Size for Reagents & Assay Kits, By Region, 2014–2021 (USD Million)
Table 8 Antinuclear Antibody Test Market Size for Systems, By Region, 2014–2021 (USD Million)
Table 9 Antinuclear Antibody Test Market Size for Software & Services, By Region, 2014–2021 (USD Million)
Table 10 Antinuclear Antibody Testing Market Size, By Technique, 2014–2021 (USD Million)
Table 11 Antinuclear Antibody Test Market Size for Elisa, By Region, 2014–2021 (USD Million)
Table 12 Antinuclear Antibody Test Market Size for Ifa, By Region, 2014–2021 (USD Million)
Table 13 Antinuclear Antibody Test Market Size for Multiplex Assays, By Region, 2014–2021 (USD Million)
Table 14 Antinuclear Antibody Test Market Size, By Disease, 2014–2021 (USD Million)
Table 15 Market Size for Rheumatoid Arthritis, By Region, 2014–2021 (USD Million)
Table 16 Market Size for Systemic Lupus Erythematosus, By Region, 2014–2021 (USD Million)
Table 17 Market Size for Sjögren’s Syndrome, By Region, 2014–2021 (USD Million)
Table 18 Market Size for Scleroderma, By Region, 2014–2021 (USD Million)
Table 19 Market Size for Other Diseases, By Region, 2014–2021 (USD Million)
Table 20 Antinuclear Antibody Test Market Size, By End User, 2014–2021 (USD Million)
Table 21 Global Antinuclear Antibody Test Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 22 Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 23 Market Size for Small Hospitals, By Region, 2014–2021 (USD Million)
Table 24 Market Size for Mid-Sized Hospitals, By Region, 2014–2021 (USD Million)
Table 25 Market Size for Large Hospitals, By Region, 2014–2021 (USD Million)
Table 26 Market Size for Clinical Laboratories, By Region, 2014–2021 (USD Million)
Table 27 Market Size for Physician Office Laboratories, By Region, 2014–2021 (USD Million)
Table 28 Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 29 Market Size, By Region, 2014–2021 (USD Million)
Table 30 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 31 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 32 North America: Market Size, By Technique, 2014–2021 (USD Million)
Table 33 North America: Market Size, By Disease, 2014–2021 (USD Million)
Table 34 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 35 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 36 U.S.: Market Size, By Technique, 2014–2021 (USD Million)
Table 37 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 38 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 39 Canada: Market Size, By Technique, 2014–2021 (USD Million)
Table 40 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 41 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 42 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 43 Europe: Market Size, By Technique, 2014–2021 (USD Million)
Table 44 Europe: Market Size, By Disease, 2014–2021 (USD Million)
Table 45 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 46 Asia: Market Size, By Country, 2014–2021 (USD Million)
Table 47 Asia: Market Size, By Product, 2014–2021 (USD Million)
Table 48 Asia: Market Size, By Technique, 2014–2021 (USD Million)
Table 49 Asia: Market Size, By Disease, 2014–2021 (USD Million)
Table 50 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 51 China: Market Size, By Product, 2014–2021 (USD Million)
Table 52 China: Market Size, By Technique, 2014–2021 (USD Million)
Table 53 China: Market Size, By End User, 2014–2021 (USD Million)
Table 54 Japan: Market Size, By Product, 2014–2021 (USD Million)
Table 55 Japan: Market Size, By Technique, 2014–2021 (USD Million)
Table 56 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 57 India: Market Size, By Product, 2014–2021 (USD Million)
Table 58 India: Market Size, By Technique, 2014–2021 (USD Million)
Table 59 India: Market Size, By End User, 2014–2021 (USD Million)
Table 60 RoA: Market Size, By Product, 2014–2021 (USD Million)
Table 61 RoA: Market Size, By Technique, 2014–2021 (USD Million)
Table 62 RoA: Market Size, By End User, 2014–2021 (USD Million)
Table 63 RoW: Market Size, By Country, 2014–2021 (USD Million)
Table 64 RoW: Market Size, By Product, 2014–2021 (USD Million)
Table 65 RoW: Market Size, By Technique, 2014–2021 (USD Million)
Table 66 RoW: Market Size, By Disease, 2014–2021 (USD Million)
Table 67 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 68 Growth Strategy Matrix, 2013–2016
Table 69 Acquisitions, 2013–2016
Table 70 Agreements, 2013–2016
Table 71 New Product Launches, 2013–2016
Table 72 Expansions, 2013–2016
Table 73 Other Developments, 2013–2016

List of Figures

Figure 1 Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Antinuclear Antibody Test Market: Bottom-Up Approach
Figure 5 Antinuclear Antibody Test Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Antinuclear Antibody Test Market Size, By Product, 2016 vs 2021 (USD Million)
Figure 8 Global Antinuclear Antibody Test Market Size, By Technique, 2016 vs 2021 (USD Million)
Figure 9 Global Antinuclear Antibody Test Market Size, By Disease Type, 2016 vs 2021 (USD Million)
Figure 10 Global Antinuclear Antibody Test Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 11 Global Antinuclear Antibody Test Market Size, By Region, 2016 vs 2021 (USD Million)
Figure 12 Global Antinuclear Antibody Test Market to Witness Moderate Growth During the Forecast Period
Figure 13 Hospitals Segment to Dominate the Global ANA Testing Market in 2016
Figure 14 Asia Projected to Witness the Fastest Growth During the Forecast Period (2016-2021)
Figure 15 Asian Market Showcases Lucrative Growth Opportunities
Figure 16 Antinuclear Antibody Testing Market Segmentation
Figure 17 ANA Testing Market: Drivers, Restraints, Opportunities, & Trends
Figure 18 Global Population Data (2010–2015), in Billion
Figure 19 Global Healthcare and Public Healthcare Spending, 2010-2015
Figure 20 Growth in Healthcare Expenditure, By Region
Figure 21 Reagents & Assay Kits to Form the Largest Product Segment in 2016
Figure 22 North America to Dominate the Antinuclear Antibody Test Market for Reagents & Assay Kits in 2016
Figure 23 North America to Dominate the Antinuclear Antibody Test Market for Systems in 2016
Figure 24 North America to Dominate the Antinuclear Antibody Test Market for Software & Services in 2016
Figure 25 Elisa Technique to Dominate the Antinuclear Antibody Testing Market in 2016
Figure 26 North America to Dominate the Antinuclear Antibody Test Market for Elisa in 2016
Figure 27 North America to Dominate the Antinuclear Antibody Test Market for Immunofluorescence Assay in 2016
Figure 28 North America to Dominate the Antinuclear Antibody Test Market for Multiplex Assays in 2016
Figure 29 Rheumatoid Arthritis to Dominate the Antinuclear Antibody Testing Market, By Disease, in 2016
Figure 30 North America to Dominate the Market for Rheumatoid Arthritis in 2016
Figure 31 North America to Dominate the Market for Systemic Lupus Erythematosus in 2016
Figure 32 North America to Dominate the Market for Sjögren’s Syndrome in 2016
Figure 33 North America to Dominate the Market for Scleroderma in 2016
Figure 34 North America to Dominate the Market for Other Diseases in 2016
Figure 35 Antinuclear Antibody Testing Market Size, By End User, 2016 (USD Million)
Figure 36 Global Antinuclear Antibody Testing Market Size for Hospitals, By Type, 2016 (USD Million)
Figure 37 North America to Dominate the Market for Hospitals in 2016
Figure 38 North America to Dominate the Market for Small Hospitals in 2016
Figure 39 North America to Dominate the Market for Mid-Sized Hospitals in 2016
Figure 40 North America to Dominate the Market for Large Hospitals in 2016
Figure 41 North America to Dominate the Market for Clinical Laboratories in 2016
Figure 42 North America to Dominate the Market for Physician Office Laboratories in 2016
Figure 43 North America to Dominate the Market for Other End Users in 2016
Figure 44 Global Economic Indicators (2005–2014)
Figure 45 Geographic Snapshot of the Antinuclear Antibody Testing Market
Figure 46 ANA Testing Market, By Region (Market Size and Growth Rate)
Figure 47 North America: Economic Indicators (2005–2014)
Figure 48 North America: Antinuclear Antibody Market Snapshot, 2016
Figure 49 North America: ANA Testing Market, By Country (Market Size and Growth Rate)
Figure 50 Reagents & Assay Kits to Account for the Largest Share of the Antinuclear Antibody Test Market in North America in 2016
Figure 51 Elisa Technique to Account for the Largest Share of the Antinuclear Antibody Test Market in 2016
Figure 52 Rheumatoid Arthritis to Account for the Largest Share of the Antinuclear Antibody Test Market in 2016
Figure 53 Hospitals to Account for the Largest Share of the ANA Testing Markets in 2016
Figure 54 U.S.: Economic Indicators (2005–2014)
Figure 55 Reagents & Assay Kits to Account for the Largest Share in 2016
Figure 56 Elisa Technique to Account for the Largest Share of the ANA Testing Market in 2016
Figure 57 Hospitals to Dominate the ANA Testing Market in 2016
Figure 58 Canada: Economic Indicators (2005–2014)
Figure 59 Reagents & Assay Kits to Account for the Largest Share in 2016
Figure 60 Elisa Technique to Account for the Largest Share of the ANA Testing Market in 2016
Figure 61 Hospitals to Dominate the ANA Testing Market in 2016
Figure 62 Europe: Economic Indicators (2005–2014)
Figure 63 Europe: ANA Testing Market, By Country (Market Size and Growth Rate)
Figure 64 Reagents & Assay Kits to Account for the Largest Share of the ANA Testing Market in 2016
Figure 65 Elisa Technique to Account for the Largest Share of the ANA Testing Market in 2016
Figure 66 Rheumatoid Arthritis to Account for the Largest Share of the ANA Testing Market in 2016
Figure 67 Hospitals to Dominate the ANA Testing Market in 2016
Figure 68 Asia: Economic Indicators (2005–2014)
Figure 69 Asia: Antinuclear Antibody Market Snapshot, 2016
Figure 70 Asia: ANA Testing Market, By Country (Market Size and Growth Rate)
Figure 71 Reagents & Assay Kits to Account for the Largest Share of the ANA Testing Market in 2016
Figure 72 Elisa Technique to Account for the Largest Share of the ANA Testing Market in 2016
Figure 73 Rheumatoid Arthritis to Account for the Largest Share of the ANA Testing Market in 2016
Figure 74 Hospitals to Dominate the ANA Testing Market in 2016
Figure 75 China: Economic Indicators (2005–2014)
Figure 76 Reagents & Assay Kits to Account for the Largest Share in 2016
Figure 77 Elisa Technique to Account for the Largest Share of the ANA Testing Market in 2016
Figure 78 Hospitals to Dominate the ANA Testing Market in 2016
Figure 79 Japan: Economic Indicators (2005–2014)
Figure 80 Reagents & Assay Kits to Account for the Largest Share in 2016
Figure 81 Elisa Technique to Account for the Largest Share of the ANA Testing Market in 2016
Figure 82 Hospitals to Dominate the ANA Testing Market in 2016
Figure 83 India: Economic Indicators (2005–2014)
Figure 84 Reagents & Assay Kits to Account for the Largest Share in 2016
Figure 85 Elisa Technique to Account for the Largest Share of the Market in 2016
Figure 86 Hospitals to Dominate the Market in 2016
Figure 87 Reagents & Assay Kits to Account for Largest Share in 2016
Figure 88 Elisa Technique to Account for the Largest Share of the Market in 2016
Figure 89 Hospitals to Dominate the Market in 2016
Figure 90 RoW: Market, By Country (Market Size and Growth Rate)
Figure 91 Reagents & Assay Kits to Account for the Largest Share of the Market in 2016
Figure 92 Elisa Technique to Account for the Largest Share of the Market in 2016
Figure 93 Rheumatoid Arthritis to Account for the Largest Share of the Market in 2016
Figure 94 Hospitals to Dominate the Market in 2016
Figure 95 New Product Launches, Acquisitions, and Agreements—Key Growth Strategies Adopted By Players in the Market
Figure 96 Market Share Analysis, By Key Player, 2014
Figure 97 Financial Performances of the Leading Market Players
Figure 98 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 99 Alere Inc.: Company Snapshot
Figure 100 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 101 Trinity Biotech PLC: Company Snapshot
Figure 102 Erba Diagnostics, Inc.: Company Snapshot

  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • Global Micro Bioreactors Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 24-Feb-2017        Price: US 3480 Onwards        Pages: 121
    Micro bioreactors are small bioreactors with volumes below several hundred milliliters and mini-reactors with volumes below 100 mL. Micro Bioreactors can often carry out several or even tens of parallel culture process at the same time, and therefore have certain high-flux characteristics. Scope of the Report: This report focuses on the Micro Bioreactors in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This repor......
  • Europe Micro Bioreactors Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 24-Feb-2017        Price: US 4480 Onwards        Pages: 121
    Micro bioreactors are small bioreactors with volumes below several hundred milliliters and mini-reactors with volumes below 100 mL. Micro Bioreactors can often carry out several or even tens of parallel culture process at the same time, and therefore have certain high-flux characteristics. Scope of the Report: This report focuses on the Micro Bioreactors in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manuf......
  • Process Analytical Technology Market by Technique (Spectroscopy, Chromatography), Measurement (On-Line, In-Line, At-Line), Products and Services (Analyzers, Probes & Sensors), End - User (Pharmaceutical Manufacturers, CRO & CMO) - Global Forecast to 2021
    Published: 22-Feb-2017        Price: US 5650 Onwards        Pages: 161
    The global process analytical technology (PAT) market is projected to reach USD 3.30 billion by 2021 from USD 1.77billion in 2016, at a CAGR of 13.3% from 2016 to 2021.Market growth is primarily driven by factors such as government regulations on drug safety, need for manufacturing process efficiency leading to quality improvement, and technological advancements in analytical devices. Other factors supporting market growth include an increase in R&D spending by pharma and biopharma compan......
  • Global Thermal Desorption Instrument Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 21-Feb-2017        Price: US 3480 Onwards        Pages: 116
    Thermal Desorption Instrument is the instrument adopts thermal desorption theory to increase the volatility of dependents or contaminants such that they can be removed (separated) from the solid matrix (typically soil, sludge or filter cake). Thermal desorption is not incineration. The volatilized contaminants are then either collected or thermally destroyed. A thermal desorption system therefore has two major components; the desorber itself and the offgas treatment system. It is an environmenta......
  • Europe Thermal Desorption Instrument Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 21-Feb-2017        Price: US 4480 Onwards        Pages: 122
    Thermal Desorption Instrument is the instrument adopts thermal desorption theory to increase the volatility of dependents or contaminants such that they can be removed (separated) from the solid matrix (typically soil, sludge or filter cake). Thermal desorption is not incineration. The volatilized contaminants are then either collected or thermally destroyed. A thermal desorption system therefore has two major components; the desorber itself and the offgas treatment system. It is an environmenta......
  • North America Capillary Rheometer Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 20-Feb-2017        Price: US 4480 Onwards        Pages: 121
    Capillary rheometry has its origins in polymer melt processing, but is also directly relevant to many other material processes such as high speed coating and printing applications. Based on controlled extrusion of a test material, capillary rheometry enables material flow and deformation properties to be characterized under conditions of high force (or pressure), high shear rate and at elevated temperature.Scope of the Report:This report focuses on the Capillary Rheometer ......
  • Global Capillary Rheometer Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 20-Feb-2017        Price: US 3480 Onwards        Pages: 121
    Capillary rheometry has its origins in polymer melt processing, but is also directly relevant to many other material processes such as high speed coating and printing applications. Based on controlled extrusion of a test material, capillary rheometry enables material flow and deformation properties to be characterized under conditions of high force (or pressure), high shear rate and at elevated temperature.Scope of the Report:This report focuses on the Capillary Rheometer ......
  • Global Microscope Slide Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 19-Feb-2017        Price: US 3480 Onwards        Pages: 116
    A microscope slide is a thin flat piece of glass used to hold objects for examination under a microscope, typically 75 by 26 mm (3 by 1 inches) and about 1 mm thick. Typically the object is placed or secured (mounted) on the slide, and then both are inserted together in the microscope for viewing. This arrangement allows several slide-mounted objects to be quickly inserted and removed from the microscope, labeled, transported, and stored in appropriate slide cases or folders.Scope of ......
  • Global NMR Spectrometer Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 19-Feb-2017        Price: US 3480 Onwards        Pages: 121
    Nuclear Magnetic Resonance spectroscopy is a powerful and theoretically complex analytical tool. Nuclear Magnetic Resonance (NMR) spectroscopy is an analytical chemistry technique used in quality control and research for determining the content and purity of a sample as well as its molecular structure. For example, NMR can quantitatively analyze mixtures containing known compounds. For unknown compounds, NMR can either be used to match against spectral libraries or to infer the basic structure d......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs